# Digital Therapeutics Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Healthcare IT](https://www.ihealthcareanalyst.com/reports/healthcare-informatics/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Digital Therapeutics (DTx) Market by Application \[Endocrinology, Psychiatry, Addiction, Neurology, Orthopedics, Others (Gastrointestinal, Cardiovascular, Respiratory, Oncology)\], Delivery Form \[Web Application, Mobile Application, Medical Device, Video Game, Others (Virtual Reality, Artificial Intelligence)\], End User (Patients, Providers, Payers) and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Digital therapeutics involves clinically evaluated, evidence-based software programs designed to deliver therapeutic interventions for preventing, managing, or treating medical disorders or diseases. These programs can function independently or alongside traditional medications and therapies, supporting various therapeutic areas such as diabetes care, mental and behavioral health, cardiovascular health, and musculoskeletal health.

The global digital therapeutics (DTx) market research report provides market size ($million 2023 to 2033), market share analysis, growth trends and forecast (CAGR%, 2025 to 2033).

The global digital therapeutics market segmented by application \[endocrinology, psychiatry, addiction, neurology, orthopedics, others (gastrointestinal, cardiovascular, respiratory, oncology)\], delivery form \[web application, mobile application, medical device, video game, others (virtual reality, artificial intelligence)\], end user (patients, providers, payers), and geography.

The global digital therapeutics market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

In addition, the global digital therapeutics market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global digital therapeutics market and profiled in this report include Akili, Inc., Amalgam Rx, AppliedVR, AptarGroup, Inc. (Voluntis S.A.), Axena Health, Inc. (Renovia, Inc.), BigHealth (Limbix Health, Inc.), Biofourmis (Biovotion AG), DarioHealth Corporation (LabStyle Innovations Ltd.), Elekta AB, Eli Lilly and Company, GAIA AG, Hygieia, Inc., Mahana Therapeutics, Inc., MindMaze, NightWare, Inc., Palo Alto Health Sciences, Inc., ResMed, Inc. (Propeller Health), Sanofi S.A., Tali Digital Ltd., Theranica Bio-Electronics Ltd., and Welldoc, Inc.

**DATA INCLUDED:** Digital Therapeutics Market Size, Digital Therapeutics Market Share, Digital Therapeutics Market Growth Rates, Digital Therapeutics Market Trends, and Digital Therapeutics Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Digital Therapeutics (DTx) Market by Application \[Endocrinology, Psychiatry, Addiction, Neurology, Orthopedics, Others (Gastrointestinal, Cardiovascular, Respiratory, Oncology)\], Delivery Form \[Web Application, Mobile Application, Medical Device, Video Game, Others (Virtual Reality, Artificial Intelligence)\], End User (Patients, Providers, Payers) and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents HI](#tab-table-of-contents-hi)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2023-2033)
    *   Forecast Estimation ($million and CAGR%, 2025-2033)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Products
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
    *   Distribution Channels
5.  **Market Segmentation** \[_refer Market Segments and Companies Tab_\]
    *   Product or Brand Type
    *   Software Type
    *   Service Type
    *   Modality Type
    *   Indication Type
    *   Technology
    *   Medical Application
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Company Profiles** \[_refer Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
8.  **Recommendations**
9.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Digital Therapeutics (DTx) Market**

1\. **Application (Therapeutic Area)**  
1.1. Endocrinology (diabetes, obesity)  
1.2. Psychiatry  
1.3. Addiction  
1.4. Neurology  
1.5. Orthopedics  
1.6. Others (Gastrointestinal, Cardiovascular, Respiratory, Oncology)

2\. **Delivery Form**  
2.1. Web Application  
2.2. Mobile Application  
2.3. Medical Device  
2.4. Video Game  
2.5. Others (Virtual Reality, Artificial Intelligence)

3\. **End User**  
3.1. Patients  
3.2. Providers  
3.3. Payers

4\. **Geography**  
4.1. North America (U.S., Canada)  
4.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)  
4.3. Asia Pacific (Japan, China, India, Rest of APAC)  
4.4. Latin America (Brazil, Mexico, Rest of LA)  
4.5. Rest of the World

5\. **Company Profiles**  
5.1. Akili, Inc.  
5.2. Amalgam Rx  
5.3. AppliedVR  
5.4. AptarGroup, Inc. (Voluntis S.A.)  
5.5. Axena Health, Inc. (Renovia, Inc.)  
5.6. BigHealth (Limbix Health, Inc.)  
5.7. Biofourmis (Biovotion AG)  
5.8. DarioHealth Corporation (LabStyle Innovations Ltd.)  
5.9. Elekta AB  
5.10. Eli Lilly and Company  
5.11. GAIA AG  
5.12. Hygieia, Inc.  
5.13. Mahana Therapeutics, Inc.  
5.14. MindMaze  
5.15. NightWare, Inc.  
5.16. Palo Alto Health Sciences, Inc.  
5.17. ResMed, Inc. (Propeller Health)  
5.18. Sanofi S.A.  
5.19. Tali Digital Ltd.  
5.20. Theranica Bio-Electronics Ltd.  
5.21. Welldoc, Inc.

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#e794868b8294a78e8f82868b938f848695828689868b9e9493c984888a)

[](# "Scroll back to top")

Search for: